Mayne Pharma Group Ltd: 2024 AGM Results of Meeting
Mayne Pharma Group Ltd: 2024 AGM presentation and business update
Mayne Pharma Group Ltd: 2024 AGM Chair's Address to Shareholders
Mayne Pharma Group Ltd: Mayne Pharma responds to media speculation
Mayne Pharma Group Ltd: Mayne Pharma investor education webinar presentation
Mayne Pharma Group Ltd: Mayne Pharma to host interactive investor education webinar
Becoming a substantial holder from IFL
Mayne Pharma Group Ltd: 2024 Notice of Annual General Meeting and shareholder pack
Mayne Pharma Group Ltd: Annual Report to shareholders
Mayne Pharma Group Ltd: 2024 Corporate Governance Statement and Appendix 4G
Mayne Pharma Group Ltd: Notification regarding unquoted securities - MYX
Mayne Pharma Group Ltd: Notification regarding unquoted securities - MYX
Mayne Pharma Group Ltd: Notification regarding unquoted securities - MYX
Mayne Pharma Group Ltd: Notification of cessation of securities - MYX
Mayne Pharma Group Ltd: Mayne Pharma presentation at HC Wainwright Conference
Mayne Pharma Group Ltd: Mayne Pharma to present at HC Wainwright conference in NY
Mayne Pharma Group Ltd: Change of Director's Interest Notice
Mayne Pharma Group Ltd: Notification regarding unquoted securities - MYX
Mayne Pharma Group Ltd: Notification of cessation of securities - MYX
Mayne Pharma Group Ltd: Civil action against Mayne Pharma discontinued in Canada
No Data
No Data